This study aims to provide a comparative mathematical analysis of drug release from swellable polymeric delivery systems to find a general model applicable to multi-mechanistic release. Drug release data from various swellable polymeric nanoparticles extracted from the literatures were applied to the eight conventional models. Coefficient of determination (R 2 ) and absolute percent error (E%) were calculated for each set as well as the overall error (OE), the number of error (NE) and the akaike information criterion (AIC) for all sets. The model has the highest R 2 and the number of the error, as well as both the lowest overall error (OE) and the akaike information criterion, was considered as the best one. Among the models Weibull (W) model produced R 2 and OE values of 0.93 and 8.79, respectively. Also, the AIC value and the number of errors less than 5% for the model was -34.93 and 46.15% of a total number of data sets respectively. Mathematical modeling of drug release from a carrier is often attempted to recognize the main determinants of the drug release rate from the carrier with the final goal of the identification of the ideal set of conditions leading to the desired release profile in vivo.
INTRODUCTION
In recent decades, increasing attention has been devoted to the nanotechnology role in various sciences including biomedical and pharmaceutical fields. Nanoparticles have emerged as promising carriers for the delivery of a wide range of therapeutic drugs. Currently many materials such as polymers, lipids, proteins, carbons, and inorganic metals are under investigation for drug delivery (Yoon et al., 2013) . To improve the delivery systems, several types of nanoparticulate systems including polymeric nanoparticles (Hamidi et al., 2011; Hamidi et al., 2012; Azadi et al., 2015) , polymeric micelles, solid nanoparticles, lipid-based nanoparticles, such as solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and lipid drug conjugate (LDC) , nanoliposomes (Azadi and Ashrafi, 2016) , inorganic nanoparticles, dendrimers, magnetic nanoparticles, Ferrofluids, and quantum dots have been introduced and investigated previously . Among the various types of nanocarriers, polymeric nanoparticles which are classified to swellable and non-swellable ones, have been considered as promising devices in controlled drug release systems. Thus swellable polymeric nanoparticles, are frequently used in such formulations to improve the therapeutic value of various drugs and bioactive molecules due to their interesting physiochemical properties containing improvement of bioavailability, specificity and prolongation of circulating time, as well as reduction of the drug side effects, and risks of toxicity (Kumari et al., 2010) . As a matter of fact "drug release" refers to a process in which a drug molecule migrates from an initial position in a polymeric system to release medium and after subjecting to pharmacokinetic procedures, eventually becoming available for its pharmacological action. Accordingly, the drug release from nanoparticles influences its pharmacological effects as a major determinant. Studies on drug release kinetics provide important information into realizing and optimizing of such formulations . A mathematical modeling of drug release from a carrier is often attempted to recognize the release mechanisms considered as an essential determinant for designing of controlled drug release systems. Additionally, kinetics with one or two parameters can represent several release data (Barzegar-Jalali et al., 2008) . Kinetic models are also capable of characterizing the in vivo release profile. Therefore, the use of in vitro drug release data to predict in vivo performance of drug substances can be considered as the rational development of controlled release formulations. This study aims to provide a comparative mathematical analysis of drug molecules release from swellable polymeric drug delivery systems to find a general model the most applicable to determine the in vivo profile.
MATERIALS AND METHODS
To study the release kinetics of various drug molecules from the swellable polymeric nanoparticles, such as chitosan, alginate, gelatin, hyaluronic acid and etc, the release data were extracted from the literatures and fitted to the following eight conventional equations: Where k KP is a constant corresponding to the geometric and structural characteristics of the device and "n" is the release exponent which determined the mechanism of the drug release. Sum square of errors (SSE), sum square of regression (SSR) and sum square of total variation (SST) were calculated by further equations:
Zero order equation:
F = k o · t
=
Where yi show the vector of dependent observed variables for an observation, yfi is a fitted variable value, y is the mean value of yi and e is the error vector. Also, the accuracy and predictability of the models were distinguished by computing of absolute percent error (E%) for each set as well as number of error (NE) for all sets as given by Eqs.
F cal i and F obs i denote calculated fraction and an observed fraction of drug released at the ith sample, respectively. The value of N is the number of data in each set and n(i) represents the number of data points with the equal or lower "E" than "i" The Akaike Information Criterion (AIC) is also used to examine the applicability of the release models. The Akaike Information Criterion is a measure of goodness of fit based on maximum likelihood.
Where n is the number of dissolution data points, p is the number of the parameters of the model, WSSR is the weighed sum of square of residues, calculated by this process:
Where w is an optional weighing factor and Fcal i and Fobs i denote calculated fraction and observed a fraction of drug released at the sample, respectively (Costa and Lobo, 2001 ).
RESULTS AND DISCUSSION
The release data of all formulations were fitted to 8 models mentioned above. The overall error, number of errors less than 5, 10, 15 and 20% and akaike information criterion for the models are shown in Table 1 ) and the regression parameters extracted from each data set was fitted to Weibull equation are given in Table 2 .
Residual sum square (RSS), total sum square (TSS) and residual minus square (RMS) were calculated to evaluate the coefficient of determination (R 2 ) for each model and the accuracy of the best-fitted data by the suggested mathematical models. The values of them which extracted from Weibull equation are shown in Table 3 . The relative sizes of the sums of squares terms demonstrate how "good" the regression is in terms of fitting the calibration data. If the regression is "perfect", R 2 will be 1.
Weibull is an empirical model has been successfully used in analysis of both rapid and extended release data due to its versatility . This study provides valuable evidence for the practicable use of the Weibull model in drug release phenomena from swellable polymeric nanoparticles. Likely there are also several studies have experimentally investigated that, the release data from swellable polymeric nanoparticles fit best with the weibull model (Yang et al., 2000; Adibkia et al., 2007; Aksungur et al., 2011; Ji et al., 2011; Bei et al., 2012; Azadi et al., 2013; Sun et al., 2014; Liu et al., 2015; Ashrafi and Azadi, 2016; Jafari-Aghdam et al., 2016) . Among the studied models,
Weibull is regarded as a favorable model which includes parameters that are sensitive to ranges of release profile. This model offers a simple relation between the parameters and geometrical characteristic of system as well as Kosmidis et al. (2003) experimentally indicate the dependence of parameters on the specific surface. As previously mentioned, t d in Weibull equation is a location parameter denotes the lag time before the onset of drug release procedure, while β, a shape parameter, characterizes the shape of the release curve and it can be linked to physiological effect as it has been discussed in earlier study (vanBoekel, 2002) . For more identification, when β=1, the shape of curve becomes an exponential profile. If β has a higher value than 1, the curve gets sigmoidal form and finally with the β lower than 1 the equation provides parabolic model (Kalam et al., 2007) . It is obvious that the external condition is capable to influence the release kinetic and be determined by the shape parameter as well (vanBoekel, 2002) . Moreover, for better characterization of the drug release mechanisms, KorsmeyerPeppas semi-empirical model was applied. In addition, Korsmeyer-Peppas model can correlate release data with release mechanisms which Weibull model cannot provide. At 1983, Korsmeyer et al. provided a relationship in drug release from a polymeric system. To discover the overall mechanism of drug release, first 60% drug release data was fitted in KorsmeyerPeppas model (Dash et al., 2010) . ln F = ln k kp + n ln t Where F stands for the fraction of drug released up to time t, k KP is a Korsmeyer-Peppas release rate constant and "n" is the release exponent. The n value is used to characterize different release mechanisms as given further.
According to the Korsmeyer-Peppas equation (Dash et al., 2010) , 0.45 ≤ n are described with a Fickian diffusion mechanism, 0.45 < n <0.89 with non-Fickian transport, n = 0.89 with Case II transport, and n > 0.89 with super case II transport.
The release exponent of Korsmeyer-Peppas equation for all data sets are shown in Table 4 . The data produced the n<0.45, 0.45<n<0.89 and 0.98<n percent of 61.5%, 33.9% and 4.6%, respectively. Based on results Weibull model seems to be more applicable for identification of drug release from swellable polymeric nanoparticles leading to the desired release profile in vivo. 
CONCLUSIONS
Since drug release kinetics provide important information into realizing and optimizing nanoparticle drug delivery systems, there are different methods for the determination of release kinetics from such formulations . In this study we try to provide a comparative mathematical analysis of drug release from swellable polymeric delivery systems to find a general model applicable to multi mechanistic release. Drug release data from various swellable polymeric nanoparticles extracted from literatures were applied to the eight conventional models. Based on results, Weibull model seems to describe the release process with the major applicability. These viewpoints endorse that Weibull model seems to be flexible enough to describe the effect of system properties on release process and be more applicable for identification of drug release from swellable polymeric nanoparticles leading to the desired release profile in vivo.
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